<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03504436</url>
  </required_header>
  <id_info>
    <org_study_id>LEO + II</org_study_id>
    <nct_id>NCT03504436</nct_id>
  </id_info>
  <brief_title>Endovascular Treatment of Wide Neck Intracranial Aneurysms With the LEO + Stent : The LEO + II Cohort Study</brief_title>
  <official_title>Evaluation of the LEO + Stent in the Endovascular Treatment of Wide Neck Intracranial Aneurysms (Fusiform, Saccular or Dissecting), Ruptured or Not Ruptured: Cohort of the Self-expanding Intracranial Stent LEO</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balt Extrusion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Balt Extrusion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multicenter, single-arm observational study to evaluate the efficacy
      and the morbi-mortality of LEO + in patients with wide neck intracranial aneurysms (fusiform,
      saccular or dissecting), ruptured or not ruptured.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 15, 2015</start_date>
  <completion_date type="Anticipated">February 12, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 12, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>18 Months</target_duration>
  <primary_outcome>
    <measure>Total aneurysmal occlusion rate</measure>
    <time_frame>18 months</time_frame>
    <description>Classification of the occlusion observed angiographically as &quot;complete occlusion&quot;, &quot;residual neck&quot; or &quot;residual aneurysm&quot; using the Montreal three-grade scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morbi-mortality</measure>
    <time_frame>18 months</time_frame>
    <description>Number of complications and/or device or procedure related adverse events</description>
  </primary_outcome>
  <enrollment type="Actual">176</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LEO +</intervention_name>
    <description>LEO +: self-expanding intracranial stent</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with ruptured or not ruptured intracranial aneurysms demonstrated by cerebral
        arteriography treated with LEO + stent
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients with ruptured or not ruptured intracranial aneurysms demonstrated by
             cerebral arteriography treated with LEO + stent

          -  Patients (or their parents for minors) must be informed and give written consent

        Exclusion Criteria:

          -  Patients (or parents) who refused to give consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2018</study_first_submitted>
  <study_first_submitted_qc>April 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2018</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

